TMZ / Glio is identical situation to our mTNBC
TMZ / Glio is identical situation to our mTNBC
-Trovdely & TMZ only treat a very small %.
With both being cold tumors;
Again, from our patent app:
Resistance of GBM is a serious problem, preventing effective treatment. The EANO and International Brain Tumor Study Group demonstrated that dose intensification fails to improve patient survival [17,42].
The combination of TMZ (standard maintenance chemotherapeutic in GBM) and Irradiation (Canton trial) prolonged survival only in patients with IDH-mutant astrocytoma WHO grade 3 and not in those with GBM [43].
The prolongation of TMZ treatment from 6 to 12 cycles extended neither progression-free nor overall survival [44].
___
Google:
IDH-mutant astrocytoma WHO grade 3 tumors occur in a percentage of glioblastoma patients, but it's important to clarify that IDH-mutant astrocytomas are primarily found in lower-grade gliomas (grades II and III), not glioblastoma (WHO grade IV). Specifically, IDH-mutant astrocytomas are commonly observed in anaplastic astrocytomas (grade III), with reports ranging from 54%. While some studies may mention IDH mutations in glioblastoma (grade IV), the frequency is significantly lower, generally reported as 15-20%.
___
So double check & confirms TMZ is "not glioblastoma". But it is a combo SOC for low grade.
Cytodyn March letter:
" CytoDyn is also in discussions with several KOLs in neuro-oncology about the possibility of initiating a pilot study in patients with GBM, also based on currently available data."
GBM is another oyster Leronlimab is about to crack wide-open....
mTNBC
CRC
GBM
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Graphic Packaging's Financial Figures: A Rough Ride Looking at the latest numbers from Graphic Packaging (NYSE: GPK), it's clear that the packaging landscape isn’t all wrapped up in a neat bow. Sure, the top line showed a slight uptick year-on-year with net sales nudging up $2 million to $2,192 million. Volumes were up too—by 1%—but that’s barely a blip when you...
Continue Reading
A Banner Quarter for AMETEK Holy smokes, AMETEK has thrown down some numbers for the third quarter of 2026 that would make any seasoned trader sit up and take notice. We’re talking record-breaking across the board: $2.22 billion in sales, marking a whopping 17% increase over last year. Now, that's not just growth—that's rocket fuel. Earnings per share rocketed up with...
Continue Reading
From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...
Continue Reading
Nordic Semiconductor's Cutting-Edge Leap Let's cut through the noise: Nordic Semiconductor's latest move in the wireless landscape is a big deal, especially if you're the sort counting beans down to the last cent. Their fresh-off-the-press nRF71 Series of Systems-On-Chip (SoCs) pulls off a neat trick: it delivers Wi-Fi, Bluetooth LE, Thread, and edge AI on one chip, and...
Continue Reading
A Monumental Launch with Deep Roots I've been around long enough to see all sorts of moves in the art world and the tech world. But what Artprice by Artmarket is pulling off here—it’s a doozy. Thierry Ehrmann’s “Diálogo entre un pensador y la IA” just went live in Spanish, and that’s not some paperback thrill ride. We’re talking about an 1,800-page piece of...
Continue Reading
Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...
Continue Reading
Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...
Continue Reading
Why Leaving Salesforce Isn't as Crazy as It Sounds Stepping away from Salesforce isn't your run-of-the-mill decision for businesses. It’s more like abandoning ship, anticipating lurking dangers: losing cherished data, facing burdensome API restrictions, and fretting over years of trapped history. It’s not as simple as flipping a switch, and that’s what keeps most...
Continue Reading
Envision's Big Bet on Green Ammonia It's a day to talk about paradigms shifting on the high seas. Envision, a heavy hitter in the green tech arena, just fueled the very first Very Large Ammonia Carrier (VLAC) with their certified green ammonia. Now, that's not just a milestone, it’s like finding a four-leaf clover in the world of maritime decarbonization—a tough nut...
Continue Reading
Unveiling the True Spirit of Shenzhen Who's got the guts to look beyond glistening skyscrapers and see what really makes a city tick today? That's what Malcolm Clarke, the maestro behind two Oscar-winning flicks, is doing with his latest documentary, Shenzhen: People Who Build the Future. He's not just swooping in to admire the skyline—he's digging deep, aiming to...
Continue Reading
Top 5 Most Recently Viewed Articles
n2 Group Strengthens HPC and AI Portfolio n2 Group, known for its innovative approaches in computing technology, has announced a significant development in its journey by acquiring X-ISS, a leading specialist in high-performance computing (HPC) and artificial intelligence (AI). This strategic acquisition is set to bolster n2 Group's existing capabilities and serve its...
Continue Reading
Dolphin Semiconductor Expands Board with New Appointments MEYLAN, France & MONTREAL, Canada - Dolphin Semiconductor, a leading provider of semiconductor IP solutions specializing in mixed-signal IP design, is announcing today the appointment of Robert LeFort as Chairman of the Board and Shelly Van Dyke as an independent Board member. These strategic appointments aim to...
Continue Reading
Renault Group's Financial Overview and Future Goals Renault Group has recently released its preliminary financial figures for the first half of 2025, reflecting the company's strategic adaptations amidst a challenging automotive market. In a climate of heightened commercial pressure and evolving consumer preferences, the group is recalibrating its financial and...
Continue Reading
Overview of SiTime Corporation's Latest Offering SiTime Corporation, recognized for its precision timing solutions, has recently concluded a notable follow-on public offering. This offering consisted of a total of 2,012,500 shares of common stock, which intriguingly included the complete exercise of the underwriters' option to acquire additional shares. Each share was...
Continue Reading
Nightingale Ice Cream Sandwiches® Reaches Kroger Nationwide Nightingale Ice Cream Sandwiches accelerates its nationwide expansion with premium handcrafted frozen treats, now available in over 2,400 Kroger Co. stores including notable retail banners. This expansion marks a significant step for the women- and veteran-owned company, known for its chef-inspired delicacies. A...
Continue Reading